Manuel A Patarroyo
Overview
Explore the profile of Manuel A Patarroyo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
174
Citations
1220
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Celis-Giraldo C, Suarez C, Agudelo W, Ibarrola N, Degano R, Diaz J, et al.
Biology (Basel)
. 2024 Oct;
13(10).
PMID: 39452141
Salmonellosis is a zoonotic infection that has a major impact on human health; consuming contaminated pork products is the main source of such infection. Vaccination responses to classic vaccines have...
2.
Reyes C, Patarroyo M
Int J Biol Macromol
. 2023 Dec;
259(Pt 1):128944.
PMID: 38145690
Self-assembly involves a set of molecules spontaneously interacting in a highly coordinated and dynamic manner to form a specific supramolecular structure having new and clearly defined properties. Many examples of...
3.
Micelly-Moreno J, Barreto-Santamaria A, Arevalo-Pinzon G, Firacative C, Gomez B, Escandon P, et al.
J Fungi (Basel)
. 2023 Dec;
9(12).
PMID: 38132750
Invasive fungal infections (IFIs) caused by species are an emerging threat globally, given that patients at-risk and antifungal resistance are increasing. Antimicrobial peptides (AMPs) have shown good therapeutic capacity against...
4.
Araujo Z, Camargo M, Moreno Perez D, Wide A, Pacheco D, Diaz Arevalo D, et al.
Hum Immunol
. 2023 Jun;
84(9):484-491.
PMID: 37380553
NRAMP1 and VDR gene polymorphisms have been variably associated with susceptibility to tuberculosis (TB) amongst populations having different genetic background. NRAMP1 and VDR gene variants' association with susceptibility to active...
5.
Pulido-Quevedo F, Arevalo-Pinzon G, Castaneda-Ramirez J, Barreto-Santamaria A, Patarroyo M, Patarroyo M
Int J Med Microbiol
. 2023 Apr;
313(3):151579.
PMID: 37030083
Plasmodium falciparum-related malaria represents a serious worldwide public health problem due to its high mortality rates. P. falciparum expresses rhoptry neck protein 4 (PfRON4) in merozoite and sporozoite rhoptries, it...
6.
Reyes C, Patarroyo M
Eur J Pharmacol
. 2023 Mar;
945:175632.
PMID: 36863555
Adjuvants represent one of the most significant biotechnological solutions regarding vaccine development, thereby broadening the amount of candidates which can now be used and tested in vaccine formulations targeting various...
7.
Sanchez-Barinas C, Vergara-Vanegas V, Gamboa-Hernandez C, Ocampo M, Cuello-Oliveros A, Patarroyo M, et al.
Immunobiology
. 2023 Feb;
228(2):152346.
PMID: 36805110
Mycobacterium tuberculosis is one of the most successful pathogens affecting humans, being the main cause of tuberculosis. It accounts for most infectious agent-related deaths worldwide; it has been estimated that...
8.
Stereo electronic principles for selecting fully-protective, chemically-synthesised malaria vaccines
Patarroyo M, Bermudez A, Alba M, Patarroyo M, Suarez C, Aza-Conde J, et al.
Front Immunol
. 2022 Nov;
13:926680.
PMID: 36341338
Major histocompatibility class II molecule-peptide-T-cell receptor (MHCII-p-TCR) complex-mediated antigen presentation for a minimal subunit-based, multi-epitope, multistage, chemically-synthesised antimalarial vaccine is essential for inducing an appropriate immune response. Deep understanding of...
9.
Pinillos I, Perez C, Torres O, Patarroyo M, Bello F
Heliyon
. 2022 Sep;
8(9):e10674.
PMID: 36164515
Insect cell lines represent a promising and expanding field as they have several research applications including biotechnology, virology, immunity, toxicology, cell signalling mechanisms and evolution. They constitute a powerful tool...
10.
Patarroyo M, Patarroyo M, Pabon L, Alba M, Bermudez A, Rugeles M, et al.
Front Immunol
. 2022 Jun;
13:859905.
PMID: 35693819
Fifty ~20-amino acid (aa)-long peptides were selected from functionally relevant SARS-CoV-2 S, M, and E proteins for trial and another 53 common ones, plus some new ones derived from the...